Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 114

1.

Use of Highly Individualized Complement Blockade Has Revolutionized Clinical Outcomes after Kidney Transplantation and Renal Epidemiology of Atypical Hemolytic Uremic Syndrome.

Zuber J, Frimat M, Caillard S, Kamar N, Gatault P, Petitprez F, Couzi L, Jourde-Chiche N, Chatelet V, Gaisne R, Bertrand D, Bamoulid J, Louis M, Sberro Soussan R, Navarro D, Westeel PF, Frimat L, Colosio C, Thierry A, Rivalan J, Albano L, Arzouk N, Cornec-Le Gall E, Claisse G, Elias M, El Karoui K, Chauvet S, Coindre JP, Rerolle JP, Tricot L, Sayegh J, Garrouste C, Charasse C, Delmas Y, Massy Z, Hourmant M, Servais A, Loirat C, Fakhouri F, Pouteil-Noble C, Peraldi MN, Legendre C, Rondeau E, Le Quintrec M, Frémeaux-Bacchi V.

J Am Soc Nephrol. 2019 Oct 1. pii: ASN.2019040331. doi: 10.1681/ASN.2019040331. [Epub ahead of print]

PMID:
31575699
2.

Identification of genetic causes for sporadic steroid-resistant nephrotic syndrome in adults.

Gribouval O, Boyer O, Hummel A, Dantal J, Martinez F, Sberro-Soussan R, Etienne I, Chauveau D, Delahousse M, Lionet A, Allard J, Pouteil Noble C, Tête MJ, Heidet L, Antignac C, Servais A.

Kidney Int. 2018 Nov;94(5):1013-1022. doi: 10.1016/j.kint.2018.07.024.

PMID:
30348286
3.

Actinomycosis: An infrequent disease in renal transplant recipients?

Rousseau C, Piroth L, Pernin V, Cassuto E, Etienne I, Jeribi A, Kamar N, Pouteil-Noble C, Mousson C.

Transpl Infect Dis. 2018 Dec;20(6):e12970. doi: 10.1111/tid.12970. Epub 2018 Aug 11.

PMID:
30055044
4.

Sirolimus for Secondary Prevention of Skin Cancer in Kidney Transplant Recipients: 5-Year Results.

Dantal J, Morelon E, Rostaing L, Goffin E, Brocard A, Tromme I, Broeders N, Del Marmol V, Chatelet V, Dompmartin A, Kessler M, Serra A, Hofbauer GFL, Kamar N, Pouteil-Noble C, Kanitakis J, Roux A, Decullier E, Euvrard S; TUMORAPA Study Group.

J Clin Oncol. 2018 Sep 1;36(25):2612-2620. doi: 10.1200/JCO.2017.76.6691. Epub 2018 Jul 17.

PMID:
30016177
5.

French law: what about a reasoned reimbursement of serum vitamin D assays?

Souberbielle JC, Benhamou CL, Cortet B, Rousière M, Roux C, Abitbol V, Annweiler C, Audran M, Bacchetta J, Bataille P, Beauchet O, Bardet R, Benachi A, Berenbaum F, Blain H, Borson-Chazot F, Breuil V, Briot K, Brunet P, Carel JC, Caron P, Chabre O, Chanson P, Chapurlat R, Cochat P, Coutant R, Christin-Maitre S, Cohen-Solal M, Combe C, Cormier C, Courbebaisse M, Debrus G, Delemer B, Deschenes G, Duquenne M, Duval G, Fardellone P, Fouque D, Friedlander G, Gauvain JB, Groussin L, Guggenbuhl P, Houillier P, Hannedouche T, Jacot W, Javier RM, Jean G, Jeandel C, Joly D, Kamenicky P, Knebelmann B, Lafage-Proust MH, LeBouc Y, Legrand E, Levy-Weil F, Linglart A, Machet L, Maheu E, Mallet E, Marcelli C, Marès P, Mariat C, Maruani G, Maugars Y, Montagnon F, Moulin B, Orcel P, Partouche H, Personne V, Pierrot-Deseilligny C, Polak M, Pouteil-Noble C, Prié D, Raynaud-Simon A, Rolland Y, Sadoul JL, Salle B, Sault C, Schott AM, Sermet-Gaudelus I, Soubrier M, Tack I, Thervet E, Tostivint I, Touraine P, Tremollières F, Urena-Torres P, Viard JP, Wemeau JL, Weryha G, Winer N, Young J, Thomas T.

Geriatr Psychol Neuropsychiatr Vieil. 2016 Dec 1;14(4):377-382. Review.

PMID:
27818369
6.

Rapamycin safeguards lymphocytes from DNA damage accumulation in vivo.

Chebel A, Catallo R, Mabon C, Bachy E, Wenner T, Salles G, Pouteil-Noble C, Ffrench M.

Eur J Cell Biol. 2016 Sep;95(9):331-41. doi: 10.1016/j.ejcb.2016.06.004. Epub 2016 Jun 15.

PMID:
27349711
7.

Contrasting effect of new HCMV pUL54 mutations on antiviral drug susceptibility: Benefits and limits of 3D analysis.

Andouard D, Mazeron MC, Ligat G, Couvreux A, Pouteil-Noble C, Cahen R, Yasdanpanah Y, Deering M, Viget N, Alain S, Hantz S.

Antiviral Res. 2016 May;129:115-119. doi: 10.1016/j.antiviral.2016.02.004. Epub 2016 Feb 10.

PMID:
26872863
8.

[Clinical efficacy of eculizumab as treatment of gemcitabine-induced thrombotic microangiopathy: A case report].

Rogier T, Gerfaud-Valentin M, Pouteil-Noble C, Taleb A, Guillet M, Noel A, Broussolle C, Sève P.

Rev Med Interne. 2016 Oct;37(10):701-704. doi: 10.1016/j.revmed.2015.12.027. Epub 2016 Jan 28. French.

PMID:
26833144
9.

One-year Results of the Effects of Rituximab on Acute Antibody-Mediated Rejection in Renal Transplantation: RITUX ERAH, a Multicenter Double-blind Randomized Placebo-controlled Trial.

Sautenet B, Blancho G, Büchler M, Morelon E, Toupance O, Barrou B, Ducloux D, Chatelet V, Moulin B, Freguin C, Hazzan M, Lang P, Legendre C, Merville P, Mourad G, Mousson C, Pouteil-Noble C, Purgus R, Rerolle JP, Sayegh J, Westeel PF, Zaoui P, Boivin H, Le Gouge A, Lebranchu Y.

Transplantation. 2016 Feb;100(2):391-9. doi: 10.1097/TP.0000000000000958.

PMID:
26555944
10.

[Weakening osteopathies, chronic kidney disease, malabsorption, biological anomalies of calium/phosphorus metabolism: appropriate indications for a reasoned reimbursment of serum vitamin D measurement].

Souberbielle JC, Benhamou CL, Cortet B, Rousière M, Roux C, Abitbol V, Annweiler C, Audran M, Bacchetta J, Bataille P, Beauchet O, Bardet R, Benachi A, Berenbaum F, Blain H, Borson-Chazot F, Breuil V, Briot K, Brunet P, Carel JC, Caron P, Chabre O, Chanson P, Chapurlat R, Cochat P, Coutant R, Christin-Maitre S, Cohen-Solal M, Combe C, Cormier C, Courbebaisse M, Debrus G, Delemer B, Deschenes G, Duquenne M, Fardellone P, Fouque D, Friedlander G, Gauvain JB, Groussin L, Guggenbuhl P, Houillier P, Hannedouche T, Jacot W, Javier RM, Jean G, Jeandel C, Joly D, Kamenicky P, Knebelmann B, Lafage-Proust MH, LeBouc Y, Legrand E, Levy-Weil F, Linglart A, Machet L, Maheu E, Mallet E, Marcelli C, Marès P, Mariat C, Maruani G, Maugars Y, Montagnon F, Moulin B, Orcel P, Partouche H, Personne V, Pierrot-Deseilligny C, Polak M, Pouteil-Noble C, Prié D, Raynaud-Simon A, Rolland Y, Sadoul JL, Salle B, Sault C, Schott AM, Sermet-Gaudelus I, Soubrier M, Tack I, Thervet É, Tostivint I, Touraine P, Tremollières F, Urena-Torres P, Viard JP, Wemeau JL, Weryha G, Winer N, Young J, Thomas T.

Ann Biol Clin (Paris). 2014 Jul-Aug;72(4):385-9. doi: 10.1684/abc.2014.0972. French. No abstract available.

11.

Is thyroid cancer recurrence risk increased after transplantation?

Tisset H, Kamar N, Faugeron I, Roy P, Pouteil-Noble C, Klein M, Mourad G, Drui D, Do Cao C, Leenhardt L, Allix I, Bonichon F, Morelon E, Leboulleux S, Kelly A, Niccoli P, Toubert ME, Frimat L, Vantyghem MC, Bournaud C, Schlumberger M, Borson-Chazot F; TUTHYREF network.

J Clin Endocrinol Metab. 2013 Oct;98(10):3981-8. doi: 10.1210/jc.2013-1357. Epub 2013 Jul 24.

PMID:
23884779
12.

Post-transplantation lymphoproliferative disorder after kidney transplantation: report of a nationwide French registry and the development of a new prognostic score.

Caillard S, Porcher R, Provot F, Dantal J, Choquet S, Durrbach A, Morelon E, Moal V, Janbon B, Alamartine E, Pouteil Noble C, Morel D, Kamar N, Buchler M, Mamzer MF, Peraldi MN, Hiesse C, Renoult E, Toupance O, Rerolle JP, Delmas S, Lang P, Lebranchu Y, Heng AE, Rebibou JM, Mousson C, Glotz D, Rivalan J, Thierry A, Etienne I, Moal MC, Albano L, Subra JF, Ouali N, Westeel PF, Delahousse M, Genin R, Hurault de Ligny B, Moulin B.

J Clin Oncol. 2013 Apr 1;31(10):1302-9. doi: 10.1200/JCO.2012.43.2344. Epub 2013 Feb 19.

PMID:
23423742
13.

Profiling sirolimus-induced inflammatory syndrome: a prospective tricentric observational study.

Buron F, Malvezzi P, Villar E, Chauvet C, Janbon B, Denis L, Brunet M, Daoud S, Cahen R, Pouteil-Noble C, Gagnieu MC, Bienvenu J, Bayle F, Morelon E, Thaunat O.

PLoS One. 2013;8(1):e53078. doi: 10.1371/journal.pone.0053078. Epub 2013 Jan 7.

14.

Effect of two injections of non-adjuvanted influenza A H1N1pdm2009 vaccine in renal transplant recipients: INSERM C09-32 TRANSFLUVAC trial.

Le Corre N, Thibault F, Pouteil Noble C, Meiffrédy V, Daoud S, Cahen R, Charreau I, Bottigioli D, Dollinger C, Aboulker JP, Autran B, Morelon E, Barrou B.

Vaccine. 2012 Dec 14;30(52):7522-8. doi: 10.1016/j.vaccine.2012.10.047. Epub 2012 Oct 25.

PMID:
23103195
15.

Sirolimus and secondary skin-cancer prevention in kidney transplantation.

Euvrard S, Morelon E, Rostaing L, Goffin E, Brocard A, Tromme I, Broeders N, del Marmol V, Chatelet V, Dompmartin A, Kessler M, Serra AL, Hofbauer GF, Pouteil-Noble C, Campistol JM, Kanitakis J, Roux AS, Decullier E, Dantal J; TUMORAPA Study Group.

N Engl J Med. 2012 Jul 26;367(4):329-39. doi: 10.1056/NEJMoa1204166.

16.

Development and validation of a predictive model for death in acquired severe ADAMTS13 deficiency-associated idiopathic thrombotic thrombocytopenic purpura: the French TMA Reference Center experience.

Benhamou Y, Assié C, Boelle PY, Buffet M, Grillberger R, Malot S, Wynckel A, Presne C, Choukroun G, Poullin P, Provôt F, Gruson D, Hamidou M, Bordessoule D, Pourrat J, Mira JP, Le Guern V, Pouteil-Noble C, Daubin C, Vanhille P, Rondeau E, Palcoux JB, Mousson C, Vigneau C, Bonmarchand G, Guidet B, Galicier L, Azoulay E, Rottensteiner H, Veyradier A, Coppo P; Thrombotic Microangiopathies Reference Center.

Haematologica. 2012 Aug;97(8):1181-6. Epub 2012 May 11.

17.

Myocardial microvascular disease and major adverse cardiovascular events in patients with end-stage renal disease: rationale and design of the MICROCARD study.

Bejan-Angoulvant T, Bergerot C, Juillard L, Mezergues A, Morelon E, Pouteil-Noble C, André-Fouët X, Angoulvant D.

Nephrol Dial Transplant. 2012 Jul;27(7):2886-91. doi: 10.1093/ndt/gfs008. Epub 2012 Feb 17.

PMID:
22344775
18.

INF2 mutations in Charcot-Marie-Tooth disease with glomerulopathy.

Boyer O, Nevo F, Plaisier E, Funalot B, Gribouval O, Benoit G, Huynh Cong E, Arrondel C, Tête MJ, Montjean R, Richard L, Karras A, Pouteil-Noble C, Balafrej L, Bonnardeaux A, Canaud G, Charasse C, Dantal J, Deschenes G, Deteix P, Dubourg O, Petiot P, Pouthier D, Leguern E, Guiochon-Mantel A, Broutin I, Gubler MC, Saunier S, Ronco P, Vallat JM, Alonso MA, Antignac C, Mollet G.

N Engl J Med. 2011 Dec 22;365(25):2377-88. doi: 10.1056/NEJMoa1109122.

19.

Impact of pretransplant human leukocyte antigen-C and -DP antibodies on kidney graft outcome.

Gilbert M, Paul S, Perrat G, Giannoli C, Pouteil Noble C, Morelon E, Rigal D, Dubois V.

Transplant Proc. 2011 Nov;43(9):3412-4. doi: 10.1016/j.transproceed.2011.09.023.

PMID:
22099809
20.

Reversible ileitis secondary to high dose intravenous immunoglobulin in adult kidney transplant patient treated for acute humoral rejection.

Ignace-Girerd S, Bouffard J, Du Besset AC, Giannoli C, Cahen R, Dijoud F, Pouteil-Noble C, Villar E.

Transpl Int. 2011 Dec;24(12):e111-4. doi: 10.1111/j.1432-2277.2011.01343.x. Epub 2011 Sep 19.

21.

Renal transplantation in patients with AA amyloidosis nephropathy: results from a French multicenter study.

Kofman T, Grimbert P, Canouï-Poitrine F, Zuber J, Garrigue V, Mousson C, Frimat L, Kamar N, Couvrat G, Bouvier N, Albano L, Le Thuaut A, Pillebout E, Choukroun G, Couzi L, Peltier J, Mariat C, Delahousse M, Buchler M, Le Pogamp P, Bridoux F, Pouteil-Noble C, Lang P, Audard V.

Am J Transplant. 2011 Nov;11(11):2423-31. doi: 10.1111/j.1600-6143.2011.03620.x. Epub 2011 Jun 30.

22.

Anemia normalization in patients with type 2 diabetes and chronic kidney disease: results of the NEPHRODIAB2 randomized trial.

Villar E, Lièvre M, Kessler M, Lemaître V, Alamartine E, Rodier M, François M, Zaoui P, Moranne O, Choukroun G, Guerraoui A, Jolivot A, Janin G, Branger B, Heng AE, Boudray C, Bissery A, Rabilloud M, Pouteil-Noble C.

J Diabetes Complications. 2011 Jul-Aug;25(4):237-43. doi: 10.1016/j.jdiacomp.2011.03.003. Epub 2011 May 20.

PMID:
21601481
23.

[Chronic renal failure].

Pouteil-Noble C.

Rev Prat. 2010 Dec 20;60(10):1431-42. French. No abstract available.

PMID:
21425548
24.

Confounding factors for early death in incident end-stage renal disease patients: Role of emergency dialysis start.

Descamps C, Labeeuw M, Trolliet P, Cahen R, Ecochard R, Pouteil-Noble C, Villar E.

Hemodial Int. 2011 Jan;15(1):23-9. doi: 10.1111/j.1542-4758.2010.00513.x. Epub 2011 Jan 12.

PMID:
21223483
25.

Outcome of kidney transplantation in type I oral-facial-digital syndrome.

Halleux D, Dahan K, Thauvin-Robinet C, Aral B, Pouteil-Noble C, Devuyst O, Pirson Y.

Transpl Int. 2011 Jun;24(6):e48-50. doi: 10.1111/j.1432-2277.2010.01208.x. Epub 2011 Jan 6. No abstract available.

26.

Immunogenicity and safety of intradermal influenza vaccination in renal transplant patients who were non-responders to conventional influenza vaccination.

Morelon E, Pouteil Noble C, Daoud S, Cahen R, Goujon-Henry C, Weber F, Laurent PE, Kaiserlian D, Nicolas JF.

Vaccine. 2010 Oct 4;28(42):6885-90. doi: 10.1016/j.vaccine.2010.08.015. Epub 2010 Aug 13.

PMID:
20709000
27.

Long-Term Impact of Cyclosporin Reduction with MMF Treatment in Chronic Allograft Dysfunction: REFERENECE Study 3-Year Follow Up.

Frimat L, Cassuto-Viguier E, Provôt F, Rostaing L, Charpentier B, Akposso K, Moal MC, Lang P, Glotz D, Caillard S, Ducloux D, Pouteil-Noble C, Girardot-Seguin S, Kessler M.

J Transplant. 2010;2010. pii: 402750. doi: 10.1155/2010/402750. Epub 2010 Jul 28.

28.

Rapidly growing orf in a renal transplant recipient: favourable outcome with reduction of immunosuppression and imiquimod.

Zaharia D, Kanitakis J, Pouteil-Noble C, Euvrard S.

Transpl Int. 2010 Oct;23(10):e62-4. doi: 10.1111/j.1432-2277.2010.01147.x.

29.

The Impact of type 2 diabetes on mortality in end-stage renal disease patients differs between genders.

Karamé A, Labeeuw M, Trolliet P, Caillette-Beaudoin A, Cahen R, Ecochard R, Galland R, Hallonet P, Pouteil-Noble C, Villar E.

Nephron Clin Pract. 2009;112(4):c268-75. doi: 10.1159/000224794. Epub 2009 Jun 16.

PMID:
19546587
30.

Interleukin 17 acts in synergy with B cell-activating factor to influence B cell biology and the pathophysiology of systemic lupus erythematosus.

Doreau A, Belot A, Bastid J, Riche B, Trescol-Biemont MC, Ranchin B, Fabien N, Cochat P, Pouteil-Noble C, Trolliet P, Durieu I, Tebib J, Kassai B, Ansieau S, Puisieux A, Eliaou JF, Bonnefoy-Bérard N.

Nat Immunol. 2009 Jul;10(7):778-85. doi: 10.1038/ni.1741. Epub 2009 May 31. Retraction in: Nat Immunol. 2014 Sep;15(9):894.

PMID:
19483719
31.

Long-term results of combined heart and kidney transplantation: a French multicenter study.

Vermes E, Grimbert P, Sebbag L, Barrou B, Pouteil-Noble C, Pavie A, Obadia JF, Loisance D, Lang P, Kirsch M.

J Heart Lung Transplant. 2009 May;28(5):440-5. doi: 10.1016/j.healun.2009.01.020. Epub 2009 Mar 14.

PMID:
19416771
32.

A Simple Modeling-free Method Provides Accurate Estimates of Sensitivity and Specificity of Longitudinal Disease Biomarkers.

Subtil F, Pouteil-Noble C, Toussaint S, Villar E, Rabilloud M.

Methods Inf Med. 2009;48(3):299-305. doi: 10.3414/ME0583. Epub 2009 Mar 31.

PMID:
19387511
33.

Nephrin mutations can cause childhood-onset steroid-resistant nephrotic syndrome.

Philippe A, Nevo F, Esquivel EL, Reklaityte D, Gribouval O, Tête MJ, Loirat C, Dantal J, Fischbach M, Pouteil-Noble C, Decramer S, Hoehne M, Benzing T, Charbit M, Niaudet P, Antignac C.

J Am Soc Nephrol. 2008 Oct;19(10):1871-8. doi: 10.1681/ASN.2008010059. Epub 2008 Jul 9.

34.

Mycophenolate mofetil monotherapy in membranous nephropathy: a 1-year randomized controlled trial.

Dussol B, Morange S, Burtey S, Indreies M, Cassuto E, Mourad G, Villar E, Pouteil-Noble C, Karaaslan H, Sichez H, Lasseur C, Delmas Y, Nogier MB, Fathallah M, Loundou A, Mayor V, Berland Y.

Am J Kidney Dis. 2008 Oct;52(4):699-705. doi: 10.1053/j.ajkd.2008.04.013. Epub 2008 Jun 30.

PMID:
18585835
35.

Prospective comparison of the use of sirolimus and cyclosporine in recipients of a kidney from an expanded criteria donor.

Durrbach A, Rostaing L, Tricot L, Ouali N, Wolf P, Pouteil-Noble C, Kessler M, Viron B, Thervet E.

Transplantation. 2008 Feb 15;85(3):486-90. doi: 10.1097/TP.0b013e318160d3c9.

PMID:
18301342
36.

[When to place a patient on the kidney transplantation waiting list?].

Kessler M, Büchler M, Durand D, Kolko-Labadens A, Lefrançois G, Menoyo V, Mourad G, Peraldi MN, Pouteil-Noble C, Yver L, Zins B, Hourmant M; Commission de transplantation de la société de néphrologie.

Nephrol Ther. 2008 Jun;4(3):155-9. doi: 10.1016/j.nephro.2007.11.008. Epub 2008 Feb 12. Review. French.

PMID:
18272442
37.

IgA-mediated autoimmune haemolytic anaemia in a 9-year renal transplanted patient.

Ignace S, Villar E, Broussais F, Moncharmont P, Vial T, Pouteil-Noble C.

NDT Plus. 2008 Feb;1(1):28-29. doi: 10.1093/ndtplus/sfm015. Epub 2007 Dec 19. No abstract available.

38.

High pretransplantation soluble CD30 levels: impact in renal transplantation.

Giannoli C, Bonnet MC, Perrat G, Houillon A, Reydet S, Pouteil-Noble C, Villar E, Lefrançois N, Morelon E, Dubois V.

Transplant Proc. 2007 Oct;39(8):2574-5.

PMID:
17954178
39.

Renal function with delayed or immediate cyclosporine microemulsion in combination with enteric-coated mycophenolate sodium and steroids: results of follow up to 30 months post-transplant.

Mourad G, Karras A, Kamar N, Garrigue V, Legendre C, Lefrançois N, Charpentier B, Bourbigot B, Pouteil-Noble C, Bayle F, Lebranchu Y, Mariat C, Le Meur Y, Kessler M, Moulin B, Ducloux D, Delahousse M, Lang P, Merville P, Chaouche-Teyara K, Rostaing L; French Myriade FR01 Study Group.

Clin Transplant. 2007 May-Jun;21(3):295-300.

PMID:
17488375
40.

Poor prognosis of heart transplant patients with end-stage renal failure.

Villar E, Boissonnat P, Sebbag L, Hendawy A, Cahen R, Trolliet P, Labeeuw M, Ecochard R, Pouteil-Noble C.

Nephrol Dial Transplant. 2007 May;22(5):1383-9. Epub 2007 Jan 31.

PMID:
17267535
41.

Tolerability of enteric-coated mycophenolate sodium to 1 year in combination with cyclosporine and corticosteroids in renal transplant recipients.

Rostaing L, Mourad G, Kamar N, Garrigue V, Karras A, Lefrançois N, Charpentier B, Bourbigot B, Pouteil-Noble C, Bayle F, Lebranchu Y, Berthoux F, Le Meur Y, Kessler M, Moulin B, Ducloux D, Delahousse M, Lang P, Merville P, Chaouche-Teyara K, Legendre C; French Myriade FR01 Study Group.

Transplant Proc. 2006 Nov;38(9):2860-3.

PMID:
17112849
42.

Impact of cyclosporine reduction with MMF: a randomized trial in chronic allograft dysfunction. The 'reference' study.

Frimat L, Cassuto-Viguier E, Charpentier B, Noël C, Provôt F, Rostaing L, Glotz D, Sraer JD, Bourbigot B, Moulin B, Lang P, Ducloux D, Pouteil-Noble C, Girardot-Seguin S, Kessler M.

Am J Transplant. 2006 Nov;6(11):2725-34.

43.

Sirolimus conversion for patients with posttransplant Kaposi's sarcoma.

Lebbé C, Euvrard S, Barrou B, Pouteil-Noble C, Garnier JL, Glotz D, Legendre C, Francès C.

Am J Transplant. 2006 Sep;6(9):2164-8. Epub 2006 Jun 19.

44.

Subsequent skin cancers in kidney and heart transplant recipients after the first squamous cell carcinoma.

Euvrard S, Kanitakis J, Decullier E, Butnaru AC, Lefrançois N, Boissonnat P, Sebbag L, Garnier JL, Pouteil-Noble C, Cahen R, Morelon E, Touraine JL, Claudy A, Chapuis F.

Transplantation. 2006 Apr 27;81(8):1093-100.

PMID:
16641592
45.

[Kaposi's sarcoma and organ transplantation: 22 cases].

Bécuwe C, Euvrard S, Bosshard S, Pouteil-Noble C, Garnier JL, Lefrançois N, Boillot O, Kanitakis J, Touraine JL, Claudy A.

Ann Dermatol Venereol. 2005 Nov;132(11 Pt 1):839-43. French.

PMID:
16327712
46.

Impact of standardized calibration on the inter-assay variation of 14 automated assays for the measurement of creatinine in human serum.

Séronie-Vivien S, Galteau MM, Carlier MC, Hadj-Aissa A, Hanser AM, Hym B, Marchal A, Michotey O, Pouteil-Noble C, Sternberg M, Perret-Liaudet A; Creatinine Working Group of the Société Française de Biologie Clinique.

Clin Chem Lab Med. 2005;43(11):1227-33.

PMID:
16232080
47.

Chronic renal failure and end-stage renal disease are associated with a high rate of mortality after heart transplantation.

Hendawy A, Pouteil-Noble C, Villar E, Boissonnat P, Sebbag L.

Transplant Proc. 2005 Mar;37(2):1352-4. Erratum in: Transplant Proc. 2005 Jul-Aug;37(6):2894. Hemdawy, A [corrected to Hendawy, A].

PMID:
15848718
48.

The cost-effectiveness of prophylaxis with valaciclovir in the management of cytomegalovirus after renal transplantation.

Legendre C, Beard SM, Crochard A, Lebranchu Y, Pouteil-Noble C, Richter A, Durand-Zaleski I.

Eur J Health Econ. 2005 Jun;6(2):172-82.

PMID:
15765243
49.

Anemia treatment and decline of renal function.

Villar E, Lievre M, Pouteil-Noble C.

Kidney Int. 2005 Feb;67(2):779; author reply 779-80. No abstract available.

50.

[Improving the interlaboratory variation for creatinine serum assay].

Séronie-Vivien S, Galteau MM, Carlier MC, Hadj-Aissa A, Hanser AM, Hym B, Marchal A, Michotey O, Pouteil-Noble C, Sternberg M, Perret-Liaudet A; SFBC "Créatinine" de la Section "Assurance qualité".

Ann Biol Clin (Paris). 2004 Mar-Apr;62(2):165-75. French.

Supplemental Content

Loading ...
Support Center